|
DNAJC28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.33360014540085E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.14109999227452E-09 |
| Normal-vs-Stage2 |
1.97739999999724E-05 |
| Normal-vs-Stage3 |
6.32219832041869E-11 |
| Normal-vs-Stage4 |
7.12352399290239E-12 |
| Stage1-vs-Stage2 |
3.136300E-02 |
| Stage1-vs-Stage3 |
9.982100E-02 |
| Stage1-vs-Stage4 |
1.925530E-02 |
| Stage2-vs-Stage3 |
2.360900E-03 |
| Stage2-vs-Stage4 |
3.043300E-04 |
| Stage3-vs-Stage4 |
3.132400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.39479983118918E-10 |
| Normal-vs-AfricanAmerican |
2.11809999999257E-05 |
| Normal-vs-Asian |
1.67560000319256E-08 |
| Caucasian-vs-AfricanAmerican |
7.305600E-01 |
| Caucasian-vs-Asian |
2.497400E-01 |
| AfricanAmerican-vs-Asian |
7.296400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.41620001573528E-09 |
| Normal-vs-Female |
2.51029974585038E-10 |
| Male-vs-Female |
2.517400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.58340024320114E-10 |
| Normal-vs-Age(41-60Yrs) |
1.92539995058638E-09 |
| Normal-vs-Age(61-80Yrs) |
1.91640003865956E-09 |
| Normal-vs-Age(81-100Yrs) |
8.753400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.207200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.582400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.968600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.140600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.622400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.505800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.70629999995953E-06 |
| Classical-VS-Follicular |
5.093800E-01 |
| Classical-VS-Other |
4.792400E-01 |
| Classical-VS-Normal |
4.3954000439328E-09 |
| Tall-VS-Follicular |
4.00410000001017E-06 |
| Tall-VS-Other |
1.618160E-01 |
| Tall-VS-Normal |
1.70796710108334E-12 |
| Follicular-VS-Other |
3.769800E-01 |
| Follicular-VS-Normal |
6.8035999944982E-08 |
| Other-VS-Normal |
3.461100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.57419996219488E-09 |
| Normal-vs-N1 |
2.18691731390663E-12 |
| N0-vs-N1 |
5.54289999999957E-05 |
|
|
